164 related articles for article (PubMed ID: 22694182)
1. Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period.
Lunelli A; Rizzo C; Puzelli S; Bella A; Montomoli E; Rota MC; Donatelli I; Pugliese A
Influenza Other Respir Viruses; 2013 May; 7(3):286-95. PubMed ID: 22694182
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
4. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.
Pebody R; Djennad A; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Galiano M; Hoschler K; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Panagiotopoulos N; Yonova I; Webb R; Moore C; Donati M; Sartaj M; Shepherd SJ; McMenamin J; de Lusignan S; Zambon M
Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387673
[TBL] [Abstract][Full Text] [Related]
5. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
[TBL] [Abstract][Full Text] [Related]
6. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
[No Abstract] [Full Text] [Related]
7. Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
Broberg E; Hungnes O; Schweiger B; Prosenc K; Daniels R; Guiomar R; Ikonen N; Kossyvakis A; Pozo F; Puzelli S; Thomas I; Waters A; Wiman Å; Meijer A
Euro Surveill; 2016 Oct; 21(41):. PubMed ID: 27762211
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
[TBL] [Abstract][Full Text] [Related]
10. Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy).
Affanni P; Colucci ME; Bracchi MT; Capobianco E; Zoni R; Caruso L; Castrucci MR; Puzelli S; Cantarelli A; Veronesi L
Acta Biomed; 2019 Sep; 90(9-S):35-44. PubMed ID: 31517888
[TBL] [Abstract][Full Text] [Related]
11. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
13. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
Valenciano M; Kissling E;
Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
[TBL] [Abstract][Full Text] [Related]
14. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
15. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.
Fielding JE; Grant KA; Papadakis G; Kelly HA
BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006
[TBL] [Abstract][Full Text] [Related]
16. The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009.
Vuong CD; Hoang PM; Nguyen HL; Nguyen HT; Nguyen TC; Le TT; Dennis DT; Kapella BK; Kile JC; Le MQ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1151-7. PubMed ID: 23137010
[TBL] [Abstract][Full Text] [Related]
17. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
Altaş AB; Bayrakdar F; Korukluoğlu G
Mikrobiyol Bul; 2016 Jul; 50(3):401-17. PubMed ID: 27525396
[TBL] [Abstract][Full Text] [Related]
18. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
19. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.
McAnerney JM; Walaza S; Tempia S; Blumberg L; Treurnicht FK; Madhi SA; Valley-Omar Z; Cohen C
Influenza Other Respir Viruses; 2017 Mar; 11(2):177-181. PubMed ID: 27865064
[TBL] [Abstract][Full Text] [Related]
20. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
